Joseph, Gowsini <br/><br/>
Plasma alpha-defensin is associated with cardiovascular morbidity and mortality in type 1 diabetic patients.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Apr 2008 
 - 1470-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-972X 
<br/><br/><label>Standard No.: </label>10.1210/jc.2007-1910  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Biomarkers<br/>Cardiovascular Diseases--etiology<br/>Diabetes Mellitus, Type 1--blood<br/>Diabetic Nephropathies--blood<br/>Female<br/>Follow-Up Studies<br/>Glomerular Filtration Rate<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Male<br/>Middle Aged<br/>Morbidity<br/>Proportional Hazards Models<br/>Prospective Studies<br/>alpha-Defensins--blood